https://www.bostontechnologyreview.com/article/910349585-sitestream-a-polaris-group-company-now-an-awarded-vendor-by-the-north-carolina-sheriffs-association Boston Technology Review en PressRelease 2026-05-04T22:55:52+00:00 Sitestream, A Polaris Group Company, now an 'Awarded Vendor' by the North Carolina Sheriffs' Association https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847402-north-carolina-sheriffs-procur-500x500.jpeg https://www.bostontechnologyreview.com/article/910262736-actually-health-announces-virtual-care-membership-that-gets-smarter-with-every-patient Boston Technology Review en PressRelease 2026-05-04T17:23:26+00:00 Actually Health Announces Virtual Care Membership That Gets Smarter With Every Patient https://www.bostontechnologyreview.com/article/910251762-lionbridge-names-sebastian-bretschneider-chief-executive-officer Boston Technology Review en PressRelease 2026-05-04T16:00:00+00:00 Lionbridge Names Sebastian Bretschneider Chief Executive Officer https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24846853-sebastian-bretschneider-461x461.jpeg https://www.bostontechnologyreview.com/article/910260314-creatio-sets-a-new-standard-for-enterprise-software-pricing-in-the-age-of-ai Boston Technology Review en PressRelease 2026-05-04T14:00:31+00:00 Creatio Sets a New Standard for Enterprise Software Pricing in the Age of AI https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24846909-unlimited-pricing-1280x628.png https://www.bostontechnologyreview.com/article/909118729-lydonia-showcases-proven-invoice-processing-solution-delivering-measurable-finance-results Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Lydonia Showcases Proven Invoice Processing Solution Delivering Measurable Finance Results https://www.bostontechnologyreview.com/article/909690194-c10-labs-and-pegasystems-launch-applied-ai-accelerator-in-cambridge-for-summer-2026 Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 C10 Labs and Pegasystems launch Applied AI Accelerator in Cambridge for Summer 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24845724-c10-labs-logo-1680x145.png https://www.bostontechnologyreview.com/article/910361222-axiant-launches-with-innovative-process-first-methodology-to-address-automation-failures Boston Technology Review en PressRelease 2026-05-04T22:42:00+00:00 Axiant Launches with Innovative Process-First Methodology to Address Automation Failures https://pressranger.s3.us-west-1.amazonaws.com/3251527/axiant-logo.png https://www.bostontechnologyreview.com/article/910342560-nanobiotix-announces-protocol-amendment-to-ongoing-global-phase-3-head-and-neck-cancer-study Boston Technology Review en PressRelease 2026-05-04T21:29:27+00:00 Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910342587-nanobiotix-annonce-un-amendement-du-protocole-de-l-tude-mondiale-de-phase-3-sur-le-cancer-de-la-t-te-et-du-cou Boston Technology Review en PressRelease 2026-05-04T21:29:27+00:00 NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910342532-edgesource-corporation-acquires-lyteworx-automation-systems-deepening-its-defense-and-intelligence-mission-capabilities Boston Technology Review en PressRelease 2026-05-04T21:28:35+00:00 Edgesource Corporation Acquires Lyteworx Automation Systems, Deepening Its Defense and Intelligence Mission Capabilities https://ml.globenewswire.com/media/ba7fdda5-6ced-4314-801e-44f9e00da542/small/edgesource-logo-pr-1200-png.png https://www.bostontechnologyreview.com/article/910342447-jiade-limited-announces-pricing-of-up-to-12-0-million-registered-direct-offering Boston Technology Review en PressRelease 2026-05-04T21:10:00+00:00 JIADE LIMITED Announces Pricing of up to $12.0 Million Registered Direct Offering https://ml.globenewswire.com/media/66c132ba-862c-42c5-92fc-aab67a82bf74/small/logo-png.png https://www.bostontechnologyreview.com/article/910342356-new-publication-demonstrates-tlx250-px-zircaix-potential-in-diagnosing-kidney-cancers-beyond-ccrcc Boston Technology Review en PressRelease 2026-05-04T21:00:00+00:00 New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.bostontechnologyreview.com/article/910333422-tango-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Boston Technology Review en PressRelease 2026-05-04T20:31:00+00:00 Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d6e37a27-2e33-43bb-ae05-bfb0dedbf190/small/tango-logo-png.png https://www.bostontechnologyreview.com/article/910333352-teva-to-present-at-the-bofa-securities-health-care-conference Boston Technology Review en PressRelease 2026-05-04T20:30:00+00:00 Teva to Present at the BofA Securities Health Care Conference https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.bostontechnologyreview.com/article/910333368-vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Boston Technology Review en PressRelease 2026-05-04T20:30:00+00:00 Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png https://www.bostontechnologyreview.com/article/910333377-cellectis-to-report-first-quarter-financial-results-on-may-11-2026 Boston Technology Review en PressRelease 2026-05-04T20:30:00+00:00 Cellectis to Report First Quarter Financial Results on May 11, 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.bostontechnologyreview.com/article/910333384-cellectis-publiera-ses-r-sultats-financiers-du-premier-trimestre-le-11-mai-2026 Boston Technology Review en PressRelease 2026-05-04T20:30:00+00:00 Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.bostontechnologyreview.com/article/910333396-crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results Boston Technology Review en PressRelease 2026-05-04T20:30:00+00:00 CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910333425-microvast-schedules-first-quarter-earnings-call Boston Technology Review en PressRelease 2026-05-04T20:30:00+00:00 Microvast Schedules First Quarter Earnings Call https://ml.globenewswire.com/media/df776795-0f3f-47ee-8207-63d8c61b98bb/small/microvast-tag-bluewhite-png.png https://www.bostontechnologyreview.com/article/910333429-opus-genetics-announces-fda-acceptance-of-opgx-lca5-into-rare-disease-evidence-principles-rdep-program Boston Technology Review en PressRelease 2026-05-04T20:30:00+00:00 Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://www.bostontechnologyreview.com/article/910333432-eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026 Boston Technology Review en PressRelease 2026-05-04T20:30:00+00:00 Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://www.bostontechnologyreview.com/article/910333456-bioage-to-host-r-d-day-focused-on-nlrp3-inhibition-on-may-8-2026 Boston Technology Review en PressRelease 2026-05-04T20:30:00+00:00 BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026 https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png https://www.bostontechnologyreview.com/article/910333491-cvrx-announces-first-patient-enrollment-in-benefit-hf-a-landmark-heart-failure-trial-evaluating-barostim-in-significantly-expanded-population Boston Technology Review en PressRelease 2026-05-04T20:30:00+00:00 CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png https://www.bostontechnologyreview.com/article/910333399-anaptys-to-participate-at-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference Boston Technology Review en PressRelease 2026-05-04T20:15:00+00:00 Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://www.bostontechnologyreview.com/article/910333489-kuvi-integrates-with-kucoin-broker-pro-to-advance-agentic-finance-adoption Boston Technology Review en PressRelease 2026-05-04T20:15:00+00:00 Kuvi Integrates with KuCoin Broker Pro to Advance Agentic Finance Adoption https://ml.globenewswire.com/media/eff106d2-82fe-40b8-a438-742d86074e01/small/555-png.png https://www.bostontechnologyreview.com/article/910324529-3-e-network-technology-signs-1-3m-convertible-note-agreement-with-institutional-investor Boston Technology Review en PressRelease 2026-05-04T20:10:00+00:00 3 E Network Technology Signs 1.3M Convertible Note Agreement with Institutional Investor https://ml.globenewswire.com/media/8f4e21c2-5e2c-4ce6-88ee-66c06500e891/small/22222-2026-01-14-183954-150-jpg.jpg https://www.bostontechnologyreview.com/article/910324540-kyntra-bio-to-report-first-quarter-2026-financial-results Boston Technology Review en PressRelease 2026-05-04T20:05:00+00:00 Kyntra Bio to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/9105c1e9-d9e3-4b68-9fc8-261fed7db250/small/kyntra-bio-r-rgb-png.png https://www.bostontechnologyreview.com/article/910324550-tactile-systems-technology-inc-reports-first-quarter-2026-financial-results Boston Technology Review en PressRelease 2026-05-04T20:05:00+00:00 Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7ecb6926-a715-4305-979c-a80795dbab83/small/tactile-medical-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910324583-rumble-announces-timing-of-first-quarter-2026-earnings-release-and-conference-call Boston Technology Review en PressRelease 2026-05-04T20:05:00+00:00 Rumble Announces Timing of First Quarter 2026 Earnings Release and Conference Call https://ml.globenewswire.com/media/e41a1c60-94cb-441c-8c8e-c8202cad5bce/small/image1-png.png https://www.bostontechnologyreview.com/article/910324622-clip-money-inc-announces-amendment-of-unsecured-convertible-notes Boston Technology Review en PressRelease 2026-05-04T20:05:00+00:00 Clip Money Inc. Announces Amendment of Unsecured Convertible Notes https://ml.globenewswire.com/media/80569958-6412-49bc-802d-e98810b40181/small/logo-800-300dpi-png.png https://www.bostontechnologyreview.com/article/910324625-everquote-announces-first-quarter-2026-financial-results Boston Technology Review en PressRelease 2026-05-04T20:05:00+00:00 EverQuote Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/86005bfc-f760-4c2f-9bfc-d896152a9bea/small/everquote-jpg.jpg https://www.bostontechnologyreview.com/article/910324647-silvaco-announces-participation-at-upcoming-investor-conferences Boston Technology Review en PressRelease 2026-05-04T20:05:00+00:00 Silvaco Announces Participation at Upcoming Investor Conferences https://ml.globenewswire.com/media/86c898ba-7d91-45b3-9db0-edb7315ddaba/small/silvaco-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910324650-capricor-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-recent-corporate-update-on-may-12 Boston Technology Review en PressRelease 2026-05-04T20:05:00+00:00 Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12 https://ml.globenewswire.com/media/16ce4387-5b8f-447c-96b8-7c453633f9bf/small/getimage-48-768x274-png.png https://www.bostontechnologyreview.com/article/910324654-lexicon-pharmaceuticals-announces-100-million-loan-facility-with-hercules-capital Boston Technology Review en PressRelease 2026-05-04T20:05:00+00:00 Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg https://www.bostontechnologyreview.com/article/910324720-aktis-oncology-initiates-phase-1b-clinical-trial-for-aky-2519-a-b7-h3-miniprotein-radioconjugate-in-metastatic-castration-resistant-prostate-cancer Boston Technology Review en PressRelease 2026-05-04T20:05:00+00:00 Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC) https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://www.bostontechnologyreview.com/article/910324766-oric-pharmaceuticals-reports-first-quarter-2026-financial-results-and-operational-updates Boston Technology Review en PressRelease 2026-05-04T20:05:00+00:00 ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png https://www.bostontechnologyreview.com/article/910324758-ocugen-announces-private-offering-of-115-million-of-convertible-senior-notes Boston Technology Review en PressRelease 2026-05-04T20:01:51+00:00 Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://www.bostontechnologyreview.com/article/910324495-praxis-precision-medicines-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026-and-participate-in-upcoming-investor-conference Boston Technology Review en PressRelease 2026-05-04T20:01:00+00:00 Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://www.bostontechnologyreview.com/article/910324509-fibrobiologics-reports-preclinical-data-showing-fibroblast-spheroids-may-actively-reprogram-the-burn-wound-environment-to-drive-healing-and-reduce Boston Technology Review en PressRelease 2026-05-04T20:01:00+00:00 FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.bostontechnologyreview.com/article/910324510-biodesix-announces-first-quarter-2026-results-and-highlights Boston Technology Review en PressRelease 2026-05-04T20:01:00+00:00 Biodesix Announces First Quarter 2026 Results and Highlights https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png https://www.bostontechnologyreview.com/article/910324629-hemab-therapeutics-announces-closing-of-upsized-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares Boston Technology Review en PressRelease 2026-05-04T20:01:00+00:00 Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/M2UyM2ExNWYtYTJjYi00M2RhLTkwZGEtNjZlYTUyMzI4NTI4LTEzMjE4MjEtMjAyNi0wNS0wNC1lbg==/tiny/Hemab-Therapeutics-Inc-.png https://www.bostontechnologyreview.com/article/910324596-cytokinetics-to-announce-topline-results-from-acacia-hcm-the-pivotal-phase-3-clinical-trial-of-aficamten-in-patients-with-non-obstructive Boston Technology Review en PressRelease 2026-05-04T20:00:00+00:00 Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026 https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.bostontechnologyreview.com/article/910324602-visionary-holdings-inc-announces-receipt-of-nasdaq-delisting-determination-letter-related-to-delinquent-listing-fees Boston Technology Review en PressRelease 2026-05-04T20:00:00+00:00 Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees https://ml.globenewswire.com/media/Mzc5NzU4NDctOGU1ZC00Y2JjLWE1YjEtMjkxMmYzYjM3M2Q3LTEzMTczMjYtMjAyNi0wNS0wNC1lbg==/tiny/Visionary-Holdings-Inc-.png https://www.bostontechnologyreview.com/article/910324663-crn-recognizes-11-employees-at-climb-channel-solutions-on-the-2026-women-of-the-channel-list-and-names-climb-s-chief-marketing-officer-as-one-of-the Boston Technology Review en PressRelease 2026-05-04T19:29:34+00:00 CRN Recognizes 11 Employees at Climb Channel Solutions on the 2026 Women of the Channel List and Names Climb’s Chief Marketing Officer as one of the 2026 Women of the Channel Power 100 https://ml.globenewswire.com/media/c7f62397-551b-4c5f-ac67-cd3baeeb84e4/small/logo-png.png https://www.bostontechnologyreview.com/article/910315198-roadzen-announces-pricing-of-8-million-registered-direct-offering-of-ordinary-shares Boston Technology Review en PressRelease 2026-05-04T19:27:19+00:00 Roadzen Announces Pricing of $8 Million Registered Direct Offering of Ordinary Shares https://ml.globenewswire.com/media/5101ee32-4aaf-4552-aa26-c4ed796caf72/small/roadzen-png.png https://www.bostontechnologyreview.com/article/910315145-liabilityscore-announces-new-platform-to-bring-credit-score-logic-to-contract-risk-built-for-small-businesses-not-lawyers Boston Technology Review en PressRelease 2026-05-04T19:20:00+00:00 LiabilityScore Announces New Platform to Bring Credit-Score Logic to Contract Risk — Built for Small Businesses, Not Lawyers https://pressranger.s3.us-west-1.amazonaws.com/3240312/Commercial-Lease-Score.jpg https://www.bostontechnologyreview.com/article/910306646-sana-commerce-appoints-brian-plackis-cheng-as-ceo Boston Technology Review en PressRelease 2026-05-04T18:20:25+00:00 Sana Commerce Appoints Brian Plackis Cheng as CEO https://ml-eu.globenewswire.com/media/ec9f9caa-d98f-47e3-acc7-b19eaab978ae/small/sana-logotype-red-rgb-png.png https://www.bostontechnologyreview.com/article/910298991-michael-haske-to-become-isolved-ceo-as-company-embarks-on-next-phase-of-ai-led-growth Boston Technology Review en PressRelease 2026-05-04T18:00:00+00:00 Michael Haske to Become isolved CEO as Company Embarks on Next Phase of AI-Led Growth https://ml.globenewswire.com/media/c7803669-a575-4be5-a22a-b9982b790c1c/small/isolved-logo-color-pos-rgb-jpg.jpg https://www.bostontechnologyreview.com/article/910298983-amazon-one-medical-glp-1-program-evaluated-how-the-new-program-works-what-it-costs-and-what-cash-pay-patients-should-know-first Boston Technology Review en PressRelease 2026-05-04T17:51:04+00:00 Amazon One Medical GLP-1 Program Evaluated: How the New Program Works, What It Costs, and What Cash-Pay Patients Should Know First https://ml.globenewswire.com/media/ee6fb8bf-1ad4-4b37-8ad6-34f3692f808e/medium/direct-meds.png https://www.bostontechnologyreview.com/article/910291456-admaxxer-surpasses-5-000-active-brands-and-1-2-billion-in-tracked-gmv-reinforcing-its-position-as-a-leading-dtc-analytics-and-ai-ad-operations Boston Technology Review en PressRelease 2026-05-04T17:05:00+00:00 Admaxxer Surpasses 5,000 Active Brands and $1.2 Billion in Tracked GMV, Reinforcing Its Position as a Leading DTC Analytics and AI Ad Operations Platform https://pressranger.s3.us-west-1.amazonaws.com/3248977/Admaxxer-Surpasses-5%2C000-Active-Brands-and-%241.2-Billion-in-Tracked-GMV%2C-Reinforcing-Its-Position-as-a-Leading-DTC-Analytics-and-AI-Ad-Operations-Platform-Press.png https://www.bostontechnologyreview.com/article/910291473-eascra-biotech-welcomes-dr-anne-yau-as-life-science-research-scientist Boston Technology Review en PressRelease 2026-05-04T17:04:04+00:00 Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist https://ml.globenewswire.com/media/1eda41c1-8c5d-43f0-9198-b0a1570f47e6/medium/dr-anne-yau.jpg https://www.bostontechnologyreview.com/article/910278459-deepinfra-closes-107m-series-b-to-power-production-scale-ai-inference Boston Technology Review en PressRelease 2026-05-04T16:00:00+00:00 DeepInfra Closes $107M Series B to Power Production-Scale AI Inference https://ml.globenewswire.com/media/f36602ae-b2cf-4f29-be62-c811818f6e32/small/deepinfra-logo-horizontal-jpg.jpg https://www.bostontechnologyreview.com/article/910278468-samba-tv-bolsters-technical-leadership-with-promotion-of-jaya-aswani-to-cto-and-appointment-of-ramzi-nasr-as-vp-of-engineering Boston Technology Review en PressRelease 2026-05-04T16:00:00+00:00 Samba TV bolsters technical leadership with promotion of Jaya Aswani to CTO and appointment of Ramzi Nasr as VP of Engineering https://ml.globenewswire.com/media/25a74fa7-09fe-4ed7-8189-1587683af145/small/samba-tv-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910278471-carahsoft-recognized-in-2025-broadcom-partner-awards Boston Technology Review en PressRelease 2026-05-04T16:00:00+00:00 Carahsoft Recognized in 2025 Broadcom Partner Awards https://ml.globenewswire.com/media/ee2f2b02-4089-4a15-93fa-0956daf4ad82/small/carahsoft-blue-logo-web-png.png https://www.bostontechnologyreview.com/article/910278515-asentum-announces-ase-token-presale-ahead-of-post-quantum-mainnet-release Boston Technology Review en PressRelease 2026-05-04T16:00:00+00:00 Asentum Announces $ASE Token Presale Ahead of Post-quantum Mainnet Release https://ml.globenewswire.com/media/ff6e601c-253e-46a5-aeb1-de722f4fdcd5/small/screenshot-2026-04-30-104146-png.png https://www.bostontechnologyreview.com/article/910278486-microcloud-hologram-inc-efficient-deterministic-quantum-state-preparation-algorithm-based-on-decision-diagrams Boston Technology Review en PressRelease 2026-05-04T15:40:00+00:00 MicroCloud Hologram Inc. Efficient Deterministic Quantum State Preparation Algorithm Based on Decision Diagrams https://ml.globenewswire.com/media/OWYyYTNlYjctOWMzYi00ZmU4LWEyMTktOTQwOWU0MGM5Y2M1LTEzMTA4OTctMjAyNi0wNS0wNC1lbg==/tiny/MicroCloud-Hologram-Inc-.png https://www.bostontechnologyreview.com/article/910278494-focus-school-software-celebrates-20-years-as-a-leading-national-provider-of-k-12-technology-solutions Boston Technology Review en PressRelease 2026-05-04T15:34:49+00:00 Focus School Software Celebrates 20 Years as a Leading National Provider of K-12 Technology Solutions https://ml.globenewswire.com/media/559730d4-2aa4-418f-81fa-507e7f90d91b/small/focus-logo-1200x630-jpg.jpg https://www.bostontechnologyreview.com/article/910272579-warmysender-reaches-15-000-users-reinforcing-position-as-top-instantly-alternative Boston Technology Review en PressRelease 2026-05-04T15:15:00+00:00 WarmySender Reaches 15,000 Users, Reinforcing Position as Top Instantly Alternative https://pressranger.s3.us-west-1.amazonaws.com/3248932/WarmySender-Reaches-15%2C000-Users%2C-Reinforcing-Position-as-Top-Instantly-Alternative-Press.png https://www.bostontechnologyreview.com/article/910272589-flyguys-launches-reality-behind-the-flight-a-new-podcast-exploring-the-world-of-reality-data-capture Boston Technology Review en PressRelease 2026-05-04T15:11:34+00:00 FlyGuys Launches “Reality: Behind the Flight,” A New Podcast Exploring the World of Reality Data Capture https://ml.globenewswire.com/media/MDIxMjMxODItNjljMi00ZmM3LTgyNDMtMzVlZmE5MWI0ODQxLTUwMDE2MjAxNy0yMDI2LTA1LTA0LWVu/tiny/FlyGuys-Inc-.png https://www.bostontechnologyreview.com/article/910272515-intuitive-ai-achieves-aws-data-and-analytics-competency-as-enterprises-reassess-the-foundations-of-ai Boston Technology Review en PressRelease 2026-05-04T15:00:00+00:00 Intuitive.ai achieves AWS Data and Analytics Competency as Enterprises Reassess the Foundations of AI https://ml.globenewswire.com/media/3fc27a9a-561c-455c-b3a6-6a83ba8090b8/small/intuitive-logo-secondary-png.png https://www.bostontechnologyreview.com/article/910272541-sophos-celebrates-22-leaders-named-to-2026-crn-women-of-the-channel-list Boston Technology Review en PressRelease 2026-05-04T14:56:39+00:00 Sophos Celebrates 22 Leaders Named to 2026 CRN Women of the Channel List https://ml.globenewswire.com/media/35db908a-b7b8-4ce0-b920-69875da346ba/small/sophos-1200x628-png.png https://www.bostontechnologyreview.com/article/910266576-polar-id-kills-the-cutout-metalenz-launches-simple-secure-face-authentication-working-under-the-phone-display Boston Technology Review en PressRelease 2026-05-04T14:45:00+00:00 Polar ID kills the cutout — Metalenz launches simple, secure, face authentication working under the phone display https://ml.globenewswire.com/media/87ed8f82-bc27-4f4a-bd6f-03b30d8f16ab/small/metalenzlogoprtemplate-png.png https://www.bostontechnologyreview.com/article/910266621-jama-software-launches-model-context-protocol-mcp-server Boston Technology Review en PressRelease 2026-05-04T14:45:00+00:00 Jama Software Launches Model Context Protocol (MCP) Server https://ml.globenewswire.com/media/0f19efa9-cf4d-43a0-9f83-4d48de067aec/small/jama-software-logo.png https://www.bostontechnologyreview.com/article/910266571-flexera-channel-leaders-spotlighted-across-the-crn-2026-women-of-the-channel-list Boston Technology Review en PressRelease 2026-05-04T14:30:00+00:00 Flexera Channel Leaders Spotlighted Across the CRN® 2026 Women of the Channel List https://ml.globenewswire.com/media/691aa193-5f37-4e50-8fec-38e34f7a5e43/small/97e88b00-acec-4133-812f-8213dba8f99b-jpg.jpg https://www.bostontechnologyreview.com/article/910262632-mmi-s-symani-surgical-system-treats-first-alzheimer-s-patient-in-groundbreaking-remind-study Boston Technology Review en PressRelease 2026-05-04T14:10:00+00:00 MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study https://ml.globenewswire.com/media/e9325bed-8fcb-4abf-b66e-6f076014b0fb/small/mmi-logo-stacked-tagline-positive-rgb1-png.png https://www.bostontechnologyreview.com/article/910262667-owlting-group-nasdaq-owls-launches-owlpay-agent-wallet-targeting-the-emerging-multi-trillion-dollar-agentic-commerce-economy Boston Technology Review en PressRelease 2026-05-04T14:07:50+00:00 OwlTing Group (NASDAQ: OWLS) Launches OwlPay Agent Wallet, Targeting the Emerging Multi-Trillion-Dollar Agentic Commerce Economy https://ml.globenewswire.com/media/5a79481c-55d1-4e33-9f88-950aa88aeec5/medium/owlting-built-the-wallet-the-agentic-economy-needs-self-cust.jpg https://www.bostontechnologyreview.com/article/910262611-research-on-new-class-of-treatments-for-ovarian-cancer-receives-725-000-in-funding-from-ovarian-cancer-canada-to-become-clinical-trial-ready Boston Technology Review en PressRelease 2026-05-04T14:00:00+00:00 Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready” https://ml.globenewswire.com/media/YWY2NGZiYWEtODcyZC00Y2I5LThkZGEtYmM5ZjlkYzFkNDMzLTEzMTI5NjUtMjAyNi0wNS0wNC1lbg==/tiny/Ovarian-Cancer-Canada.png https://www.bostontechnologyreview.com/article/910262624-inqi-launches-ai-native-property-intelligence-platform-with-new-editor-and-expanded-iq-apps Boston Technology Review en PressRelease 2026-05-04T14:00:00+00:00 InQI Launches AI-Native Property Intelligence Platform with New Editor and Expanded IQ Apps https://pressranger.s3.us-west-1.amazonaws.com/3244005/inqi_image_2.png https://www.bostontechnologyreview.com/article/910262626-spring-allergies-hit-lungs-hard-doctor-of-pharmacy-explains-what-actually-helps Boston Technology Review en PressRelease 2026-05-04T14:00:00+00:00 Spring Allergies Hit Lungs Hard: Doctor of Pharmacy Explains What Actually Helps https://ml.globenewswire.com/media/13a92186-d8d0-4494-9e0a-5fc1d2e363ee/small/betterbrand-logo-new-png.png https://www.bostontechnologyreview.com/article/910258304-talkdesk-announces-new-integration-to-deliver-unified-healthcare-experience-and-outcomes-analytics Boston Technology Review en PressRelease 2026-05-04T13:32:15+00:00 Talkdesk announces new integration to deliver unified healthcare experience and outcomes analytics https://ml.globenewswire.com/media/b806fec8-0de9-496b-9ddc-7775b20acf14/small/talkdesk-logo-png.PNG https://www.bostontechnologyreview.com/article/910258255-coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026 Boston Technology Review en PressRelease 2026-05-04T13:30:00+00:00 Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/07437af0-8ae3-48cf-952b-18bc6b99ca7c/small/coherus-onc-logo-rgb-150-png.png https://www.bostontechnologyreview.com/article/910258274-intouch-insight-study-finds-mobile-ordering-success-hinges-on-reliability-not-speed Boston Technology Review en PressRelease 2026-05-04T13:30:00+00:00 Intouch Insight Study Finds Mobile Ordering Success Hinges on Reliability, Not Speed https://ml.globenewswire.com/media/MDhhNGZhN2MtZWVhZi00MWIwLTkxZDEtNmUyMjQ1ODIxMzM0LTUwMDE1NjYxNy0yMDI2LTA1LTA0LWVu/tiny/Intouch-Insight.png https://www.bostontechnologyreview.com/article/910258286-alpha-tau-announces-100-local-disease-control-rate-and-favorable-safety-profile-observed-in-alpha-dart-pancreatic-cancer-trials-presented-at-ddw Boston Technology Review en PressRelease 2026-05-04T13:17:21+00:00 Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026 https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910258285-alternative-ballistics-corporation-otcqb-albc-to-host-corporate-update-call-on-may-7-2026-at-8-30-am-et Boston Technology Review en PressRelease 2026-05-04T13:15:00+00:00 Alternative Ballistics Corporation (OTCQB: ALBC) to Host Corporate Update Call on May 7, 2026 at 8:30 AM ET https://ml.globenewswire.com/media/6f3eddb5-8d1a-420e-b07f-3e21f440c666/small/albc-logo-png.png https://www.bostontechnologyreview.com/article/910252863-prismatic-launches-skills-for-claude-code-to-help-developers-ship-integrations-faster Boston Technology Review en PressRelease 2026-05-04T13:05:00+00:00 Prismatic Launches Skills for Claude Code to Help Developers Ship Integrations Faster https://ml.globenewswire.com/media/3ffa5f28-f782-4562-9961-b68fe61d97c2/medium/prismatic-launches-skills-for-claude-code.png https://www.bostontechnologyreview.com/article/910253033-greece-launches-world-s-first-national-wildfire-satellite-system-with-ororatech Boston Technology Review en PressRelease 2026-05-04T13:04:00+00:00 Greece Launches World’s First National Wildfire Satellite System with OroraTech https://ml.globenewswire.com/media/f405d4dd-2633-4e23-8086-bbaa6bf83b25/medium/ororatech-s-hellenic-fire-system.jpg https://www.bostontechnologyreview.com/article/910253114-aura-biosciences-announces-pricing-of-260-million-public-offering-of-common-stock-and-pre-funded-warrants Boston Technology Review en PressRelease 2026-05-04T13:03:06+00:00 Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.bostontechnologyreview.com/article/910252843-operant-ai-launches-endpoint-protector-securing-shadow-ai-coding-agents-and-mcp-across-the-enterprise Boston Technology Review en PressRelease 2026-05-04T13:00:00+00:00 Operant AI Launches Endpoint Protector: Securing Shadow AI, Coding Agents, and MCP Across the Enterprise https://ml.globenewswire.com/media/cf992a83-aa53-4fbe-8acd-1dbc5d0de200/small/operant-black-logo-master-png-png.png https://www.bostontechnologyreview.com/article/910252851-asus-releases-2026-future-of-small-business-report Boston Technology Review en PressRelease 2026-05-04T13:00:00+00:00 ASUS Releases 2026 Future of Small Business Report https://pressranger.s3.us-west-1.amazonaws.com/3239907/Future-of-SMB-Report.png https://www.bostontechnologyreview.com/article/910252862-carnosyn-brands-expands-tribsyn-applications-across-beverage-dairy-and-medical-nutrition Boston Technology Review en PressRelease 2026-05-04T13:00:00+00:00 CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition https://ml.globenewswire.com/media/4b40dd5b-0137-41f8-83de-422e4b4f3196/small/nai-full-logo-green2-0-png.png https://www.bostontechnologyreview.com/article/910252869-oncolytics-biotech-reports-durable-responses-in-second-line-ras-mutant-mss-colorectal-cancer Boston Technology Review en PressRelease 2026-05-04T13:00:00+00:00 Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer https://ml.globenewswire.com/media/f0121259-b2be-4290-90a3-0d2c3b243aed/small/oncolytics-biotech-jpg.jpg https://www.bostontechnologyreview.com/article/910252951-turtle-beach-corporation-restructures-credit-facilities-to-enhance-capital-return-flexibility Boston Technology Review en PressRelease 2026-05-04T13:00:00+00:00 Turtle Beach Corporation Restructures Credit Facilities to Enhance Capital Return Flexibility https://ml.globenewswire.com/media/f8a9689c-6753-486d-b902-84d519018cbe/small/turtlebeachcorp-logo-stacked-blk-28-11-2023-jpg.jpg https://www.bostontechnologyreview.com/article/910252971-fate-therapeutics-announces-three-presentations-at-the-2026-asgct-annual-meeting-highlighting-off-the-shelf-car-t-cell-therapy-pipeline-for-cancer-and Boston Technology Review en PressRelease 2026-05-04T13:00:00+00:00 Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://www.bostontechnologyreview.com/article/910253027-quantum-x-labs-files-u-s-patent-application-for-high-precision-quantum-atomic-clock-for-potential-use-in-the-aerospace-defense-industries Boston Technology Review en PressRelease 2026-05-04T12:52:00+00:00 Quantum X Labs Files U.S. Patent Application for High Precision Quantum Atomic Clock for Potential Use in the Aerospace & Defense Industries https://ml.globenewswire.com/media/a0abc50a-ff3e-420e-9e21-807bbc6417cd/small/logo-png.png https://www.bostontechnologyreview.com/article/910253043-gyre-therapeutics-completes-acquisition-of-cullgen-to-create-u-s-and-china-based-fully-integrated-biopharmaceutical-company Boston Technology Review en PressRelease 2026-05-04T12:47:47+00:00 Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company https://ml.globenewswire.com/media/24951768-57e9-4d7a-b969-f00258b17136/small/gyre-logo-png.png https://www.bostontechnologyreview.com/article/910253010-polyrizon-announces-u-s-patent-expansion-for-its-intranasal-drug-delivery-platform Boston Technology Review en PressRelease 2026-05-04T12:45:00+00:00 Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform https://ml.globenewswire.com/media/YWIxMzIzNDgtN2UwNy00NTAyLThjZDMtZWMwNGFjZTdmNWJhLTUwMDEyOTIyMy0yMDI2LTA1LTA0LWVu/tiny/Polyrizon-Ltd-.png https://www.bostontechnologyreview.com/article/910252891-aitx-to-present-at-the-ld-micro-invitational-xvi Boston Technology Review en PressRelease 2026-05-04T12:40:00+00:00 AITX to Present at the LD Micro Invitational XVI https://ml.globenewswire.com/media/882a78f6-94c4-4a5c-a750-564a6dea2bb5/small/aitx-logo-1920x1080-2-png.png https://www.bostontechnologyreview.com/article/910247553-mapi-pharma-explores-u-s-aseptic-manufacturing-facility-to-support-growing-demand-for-aseptic-and-long-acting-generic-and-innovative-injectables Boston Technology Review en PressRelease 2026-05-04T12:30:00+00:00 Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables https://ml.globenewswire.com/media/a15e698a-0f26-4d44-bf6a-78b7ae34d25d/small/mapi-pharma-logo-png.png https://www.bostontechnologyreview.com/article/910247597-abeona-therapeutics-announces-date-of-first-quarter-financial-results Boston Technology Review en PressRelease 2026-05-04T12:30:00+00:00 Abeona Therapeutics® Announces Date of First Quarter Financial Results https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png https://www.bostontechnologyreview.com/article/910247608-satellogic-expands-global-sales-force-with-senior-defense-and-intelligence-industry-veterans Boston Technology Review en PressRelease 2026-05-04T12:30:00+00:00 Satellogic Expands Global Sales Force with Senior Defense and Intelligence Industry Veterans https://ml.globenewswire.com/media/d2d0c386-2a99-4434-aa48-fc69a11ff8a7/small/satellogic-logo-png.png https://www.bostontechnologyreview.com/article/910247610-fibrobiologics-announces-release-of-cywc628-drug-product-for-phase-1-2-diabetic-foot-ulcer-clinical-trial Boston Technology Review en PressRelease 2026-05-04T12:30:00+00:00 FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.bostontechnologyreview.com/article/910247630-fortress-biotech-to-participate-in-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference Boston Technology Review en PressRelease 2026-05-04T12:30:00+00:00 Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference https://ml.globenewswire.com/media/d82bf2ce-81b7-4989-9e6b-08e6bb6e1f95/small/fortressbio1-jpg.jpg https://www.bostontechnologyreview.com/article/910247641-service-robotics-growth-accelerates-as-global-demand-fuels-strategic-expansion Boston Technology Review en PressRelease 2026-05-04T12:30:00+00:00 Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion https://ml.globenewswire.com/media/45ff7033-6ad2-41ba-bbd1-912eb2907b3e/small/ainewswire-002-png.png https://www.bostontechnologyreview.com/article/910247668-liquidia-corporation-to-report-first-quarter-2026-financial-results-on-may-11-2026 Boston Technology Review en PressRelease 2026-05-04T12:30:00+00:00 Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/f7659070-cc55-4e68-ae70-33013e7df72c/small/liquidia-new-logo-png.png https://www.bostontechnologyreview.com/article/910247674-newgen-provides-update-on-fiscal-year-2025-results-and-strategic-progress Boston Technology Review en PressRelease 2026-05-04T12:30:00+00:00 NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress https://ml.globenewswire.com/media/ZWQwY2VjNmQtYTdlZi00YTUxLTg3NmItMmI3OWVkMTQ5MGQ4LTEyOTcwMTEtMjAyNi0wNS0wNC1lbg==/tiny/NewGenIvf-Limited.png https://www.bostontechnologyreview.com/article/910247689-axe-compute-inc-nasdaq-agpu-ceo-chris-miglino-to-appear-on-schwab-network-may-4-and-cheddar-may-6 Boston Technology Review en PressRelease 2026-05-04T12:30:00+00:00 Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6 https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png https://www.bostontechnologyreview.com/article/910242598-candel-therapeutics-to-host-investor-conference-call-following-presentation-of-extended-data-from-phase-3-trial-of-aglatimagene-besadenovec-in Boston Technology Review en PressRelease 2026-05-04T12:05:00+00:00 Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.bostontechnologyreview.com/article/910242367-proqr-announces-annual-general-meeting-of-shareholders-to-be-held-june-2-2026 Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png https://www.bostontechnologyreview.com/article/910242370-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial https://ml-eu.globenewswire.com/media/7cf77d4a-25b5-4471-a282-0334907cbfbd/small/falk-logo-rgb-jpg.jpg https://www.bostontechnologyreview.com/article/910242372-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial https://ml-eu.globenewswire.com/media/540f0a78-db35-42ad-9e90-7b81e8ff3ad6/small/renirl-logo-png.png https://www.bostontechnologyreview.com/article/910242373-cptx-to-present-preclinical-proof-of-principle-of-its-dna-based-in-vivo-car-t-platform-at-asgct-annual-meeting Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting https://ml-eu.globenewswire.com/media/b3ec9ca7-8866-466a-9d91-09342002e341/small/cptx-logo-high-res-png.png https://www.bostontechnologyreview.com/article/910242419-evaxion-to-announce-business-update-and-first-quarter-2026-financial-results-on-may-7-2026 Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026 https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://www.bostontechnologyreview.com/article/910242435-recludix-pharma-announces-upcoming-oral-presentations-on-preclinical-data-for-oral-stat6-inhibitor-rex-8756-and-topical-stat-1-3-inhibitors-at-the Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting https://ml.globenewswire.com/media/NDM5ZGUzYTItNGI0Zi00N2Y3LWE3Y2QtZmViNDYyN2I1ZWRjLTEyMzYyMjItMjAyNi0wNS0wNC1lbg==/tiny/Recludix-Pharma-Inc-.png https://www.bostontechnologyreview.com/article/910242438-rhythm-pharmaceuticals-announces-new-data-presentations-in-acquired-hypothalamic-obesity-at-pediatric-endocrine-society Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.bostontechnologyreview.com/article/910242442-spur-therapeutics-presents-clinical-insights-on-bone-disease-impact-of-flt201-in-adults-with-gaucher-disease-type-1 Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1 https://ml.globenewswire.com/media/195ccecc-f977-4fb5-ba01-43af7ec47589/small/spur-therapeutics-black-wopacity-rgb-png.png https://www.bostontechnologyreview.com/article/910242445-zoom-recognizes-the-rise-of-ai-powered-businesses-of-one-with-inaugural-solopreneur-50 Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Zoom Recognizes the Rise of AI-Powered Businesses of One with Inaugural Solopreneur 50 https://ml.globenewswire.com/media/1a5e6f52-9a8e-432b-84cc-7dfb0e6623e2/small/logo-zm-app-icon-container-png.png https://www.bostontechnologyreview.com/article/910242449-kyverna-therapeutics-appoints-nadia-dac-seasoned-commercial-leader-in-neurology-and-rare-disease-as-chief-commercial-officer Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.bostontechnologyreview.com/article/910242457-4dmt-to-participate-in-upcoming-investor-conferences Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 4DMT to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png https://www.bostontechnologyreview.com/article/910242470-valitor-presents-preclinical-data-demonstrating-superior-durability-with-six-month-treatment-protocol-of-vltr-559-to-treat-wet-amd Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png https://www.bostontechnologyreview.com/article/910242472-applied-digital-announces-300-million-senior-secured-bridge-facility Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Applied Digital Announces $300 Million Senior Secured Bridge Facility https://ml.globenewswire.com/media/a09f7f80-1e66-44ed-b53a-6007ec7be92a/small/applied-digital-logo-horizontal-black-png.png https://www.bostontechnologyreview.com/article/910242494-tessell-appoints-matt-mcdonough-and-jeffrey-carter-to-executive-team-to-accelerate-enterprise-database-modernization Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Tessell Appoints Matt McDonough and Jeffrey Carter to Executive Team to Accelerate Enterprise Database Modernization https://ml.globenewswire.com/media/503f121a-0162-4ce3-84b3-ae5e04dc98e5/medium/jeff-carter-chief-strategy-officer.jpeg https://www.bostontechnologyreview.com/article/910242516-kaltura-open-sources-suite-of-ai-agent-skills-enabling-any-ai-agent-to-build-intelligent-rich-media-digital-experiences Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Kaltura Open-Sources Suite of AI Agent Skills, Enabling Any AI Agent to Build Intelligent Rich-Media Digital Experiences https://ml.globenewswire.com/media/584e487b-dd12-4a20-a5b1-c42f4579d369/small/kaltura-logo-vertical-colorsun-blacktext-small.png https://www.bostontechnologyreview.com/article/910242538-lifeward-announces-new-rewalk-data-presented-at-asia-2026-conference-demonstrating-a-comprehensive-longitudinal-safety-analysis-for-a-powered Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg https://www.bostontechnologyreview.com/article/910242564-atsena-presents-positive-interim-six-month-results-from-part-b-of-phase-1-2-3-lighthouse-trial-evaluating-atsn-201-in-patients-with-x-linked Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910242567-rocket-doctor-ai-reports-strong-2025-results-validating-physician-led-model-with-key-u-s-payer-contracts-and-ai-innovation Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation https://ml.globenewswire.com/media/648c6dd6-c4c0-4ceb-9a78-26fecd4678a7/small/rocket-doctor-logo-250821-png.png https://www.bostontechnologyreview.com/article/910242574-after-successful-fda-meeting-clene-filing-accelerated-approval-nda-for-als Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png https://www.bostontechnologyreview.com/article/910242582-legend-biotech-expands-scientific-advisory-expertise-to-inform-future-growth Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png https://www.bostontechnologyreview.com/article/910242595-swarmer-partners-with-rakuten-to-enter-japan-s-advanced-autonomy-market Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Swarmer Partners With Rakuten to Enter Japan's Advanced Autonomy Market https://ml.globenewswire.com/media/46b28796-9654-4d2b-89db-91de399ba76a/small/swarmer-logo-dark-png.png https://www.bostontechnologyreview.com/article/910242608-ruanyun-edai-technology-s-saudi-rhq-signs-mou-with-wadi-makkah-a-subsidiary-of-umm-al-qura-university Boston Technology Review en PressRelease 2026-05-04T12:00:00+00:00 Ruanyun Edai Technology’s Saudi RHQ Signs MOU with Wadi Makkah, A Subsidiary of Umm Al-Qura University https://ml.globenewswire.com/media/0b7372f3-6354-4bba-acc5-bb10b1de4c3a/small/logo-jpg.jpg https://www.bostontechnologyreview.com/article/910237832-macrogenics-and-sagard-healthcare-partners-enter-into-expanded-zynyz-royalty-purchase-agreement Boston Technology Review en PressRelease 2026-05-04T11:30:00+00:00 MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png https://www.bostontechnologyreview.com/article/910237841-bridgebio-to-present-new-acoramidis-data-on-disease-progression-biomarkers-and-clinical-outcomes-at-esc-heart-failure-2026 Boston Technology Review en PressRelease 2026-05-04T11:30:00+00:00 BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026 https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.bostontechnologyreview.com/article/910237849-kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Boston Technology Review en PressRelease 2026-05-04T11:30:00+00:00 Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.bostontechnologyreview.com/article/910237860-palvella-therapeutics-announces-first-patients-dosed-in-phase-2-lotu-trial-of-fast-track-designated-qtorin-rapamycin-for-clinically-significant Boston Technology Review en PressRelease 2026-05-04T11:30:00+00:00 Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.bostontechnologyreview.com/article/910237878-inflarx-reports-favorable-reactive-metabolite-profile-for-izicopan-in-human-liver-microsomes Boston Technology Review en PressRelease 2026-05-04T11:30:00+00:00 InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.bostontechnologyreview.com/article/910237897-earthdaily-advancing-daily-global-measurement-of-planetary-change-with-six-satellites-launched Boston Technology Review en PressRelease 2026-05-04T11:30:00+00:00 EarthDaily Advancing Daily Global Measurement of Planetary Change with Six Satellites Launched https://ml.globenewswire.com/media/63895f31-922c-451d-894e-110f2f640ad9/medium/earthdaily-satellite-deploys.png https://www.bostontechnologyreview.com/article/910237911-windward-bio-announces-165m-crossover-financing-to-advance-pipeline-of-long-acting-immunology-therapies-with-best-in-disease-potential Boston Technology Review en PressRelease 2026-05-04T11:30:00+00:00 Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential https://ml.globenewswire.com/media/Nzk5NDkzNGQtNWZiNi00MGZkLTg2ZTAtYzViNDkwNTJjOTVmLTUwMDEzMTYxMS0yMDI2LTA1LTA0LWVu/tiny/Windward-Bio.png https://www.bostontechnologyreview.com/article/910237925-micropolis-robotics-unveils-new-next-generation-high-endurance-robot-at-the-make-it-in-the-emirates-2026-industry-exhibition Boston Technology Review en PressRelease 2026-05-04T11:29:19+00:00 Micropolis Robotics Unveils New, Next-Generation, High-Endurance Robot at the Make it in the Emirates 2026 Industry Exhibition https://ml.globenewswire.com/media/ffdb8f0a-5da0-4cdc-9a97-852140e69d8b/medium/m1-5.JPG https://www.bostontechnologyreview.com/article/910237843-cartesian-therapeutics-announces-new-employment-inducement-grants Boston Technology Review en PressRelease 2026-05-04T11:05:00+00:00 Cartesian Therapeutics Announces New Employment Inducement Grants https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png https://www.bostontechnologyreview.com/article/910237845-nextcure-and-simcere-zaiming-initiate-dose-optimization-for-sim0505-cdh6-adc-in-gynecologic-cancers Boston Technology Review en PressRelease 2026-05-04T11:05:00+00:00 NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg https://www.bostontechnologyreview.com/article/910237870-kraig-biocraft-laboratories-launches-april-may-production-cycle-following-record-spider-silk-output Boston Technology Review en PressRelease 2026-05-04T11:05:00+00:00 Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910233519-ardena-strengthens-executive-team-to-drive-its-next-phase-of-growth Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Ardena Strengthens Executive Team to Drive its Next Phase of Growth https://ml-eu.globenewswire.com/media/eddef504-18ee-4f10-8442-9e61ef77e262/medium/ardena-appoints-cfo-and-cco.png https://www.bostontechnologyreview.com/article/910233520-indivior-announces-175-million-accelerated-share-repurchase Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Indivior Announces $175 Million Accelerated Share Repurchase https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910233589-advanced-technology-recycling-atr-announces-that-they-are-now-offering-wholesale-electronics-to-the-general-public-through-their-online-auction-site Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Advanced Technology Recycling (ATR) Announces That They Are Now Offering Wholesale Electronics to the General Public Through Their Online Auction Site https://ml.globenewswire.com/media/437d4f24-24b9-4cd4-961b-ea5dd0ab80ce/small/atr-logo-with-registered-trademark-badge-jpg.jpg https://www.bostontechnologyreview.com/article/910233590-biocryst-announces-european-licensing-agreement-with-irish-affiliate-of-neopharmed-gentili-for-navenibart-in-hereditary-angioedema Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://www.bostontechnologyreview.com/article/910233621-tenax-therapeutics-appoints-timothy-healey-mba-as-chief-commercial-officer Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg https://www.bostontechnologyreview.com/article/910233629-krystal-biotech-announces-first-quarter-2026-financial-and-operating-results Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Krystal Biotech Announces First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png https://www.bostontechnologyreview.com/article/910233642-10-barrel-brewing-launches-clean-slate-and-salty-sips-expanding-rtd-line-with-functional-n-a-and-low-sugar-cocktails Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails https://ml.globenewswire.com/media/5e71b27b-1cc8-4780-8689-8d8d6ae86236/medium/clean-slate-and-salty-sips.png https://www.bostontechnologyreview.com/article/910233645-seres-therapeutics-presents-preclinical-data-at-digestive-disease-week-ddw-2026-supporting-ser-603-a-next-generation-cultivated-live-biotherapeutic Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://www.bostontechnologyreview.com/article/910233649-centrum-launches-newly-reformulated-adults-50-complete-multivitamin-with-clinically-shown-cognitive-benefits Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits https://ml.globenewswire.com/media/395df94a-8079-4f58-9b54-df434e56ec33/medium/centrum-adults-50-complete-multivitamin.png https://www.bostontechnologyreview.com/article/910233653-centrum-lance-sa-multivitamine-compl-te-adultes-50-nouvellement-reformul-e-avec-des-bienfaits-cognitifs-d-montr-s-cliniquement Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Centrum lance sa multivitamine complète Adultes 50+ nouvellement reformulée avec des bienfaits cognitifs démontrés cliniquement https://ml.globenewswire.com/media/abbbfaf3-e52b-413c-9ded-52f74cf50911/medium/centrum-multivitamine-complete-pour-adultes-50.png https://www.bostontechnologyreview.com/article/910233661-genyro-announces-new-paper-demonstrating-how-sidewinder-technology-democratizes-dna-construction-at-scale-and-facilitates-ai-driven-protein-design Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Genyro Announces New Paper Demonstrating How Sidewinder Technology Democratizes DNA Construction at Scale and Facilitates AI-Driven Protein Design https://ml.globenewswire.com/media/346f123b-cc5d-4de0-a31f-9c4f1315c070/medium/genyro-co-founders.jpg https://www.bostontechnologyreview.com/article/910233678-seer-announces-appointment-of-anthony-bazarko-as-chief-commercial-officer Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer https://ml.globenewswire.com/media/ecdddbc3-8a58-4cba-a4a1-33971e79339a/medium/anthony-bazarko.jpg https://www.bostontechnologyreview.com/article/910233683-istios-health-partners-with-care-id-to-expand-national-infectious-disease-clinical-research-network Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Istios Health Partners with CARE-ID to Expand National Infectious Disease Clinical Research Network https://ml.globenewswire.com/media/MTI0OGVmYTMtNmZkNC00ODA4LWJlNzUtNTYxODJlODcxNDBmLTEzMTYxMjEtMjAyNi0wNS0wNC1lbg==/tiny/Istios-Health.png https://www.bostontechnologyreview.com/article/910233687-adma-biologics-announces-fda-approval-to-expand-the-label-for-asceniv-to-include-pediatric-immune-compromised-patients-two-years-of-age-and-older Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg https://www.bostontechnologyreview.com/article/910233694-meet-sprysite-the-website-builder-and-marketing-platform-redefining-small-business-websites Boston Technology Review en PressRelease 2026-05-04T11:00:00+00:00 Meet SprySite: The Website Builder and Marketing Platform Redefining Small Business Websites https://pressranger.s3.us-west-1.amazonaws.com/3244560/sprypro.png https://www.bostontechnologyreview.com/article/910233575-descartes-sets-date-to-announce-first-quarter-fiscal-2027-financial-results Boston Technology Review en PressRelease 2026-05-04T10:45:00+00:00 Descartes Sets Date to Announce First Quarter Fiscal 2027 Financial Results https://ml.globenewswire.com/media/2fab20c0-6dcb-4891-840a-37d0d482f33a/small/descartes-systems-group-logo-jpg.jpg https://www.bostontechnologyreview.com/article/910233704-cabaletta-bio-announces-pricing-of-150-million-underwritten-offering Boston Technology Review en PressRelease 2026-05-04T10:35:54+00:00 Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering https://ml.globenewswire.com/media/44175396-6bbb-435f-b037-54a4052160d4/small/cabaletta-bio-registered-logo-png.png https://www.bostontechnologyreview.com/article/910224348-aura-biosciences-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants Boston Technology Review en PressRelease 2026-05-04T10:03:00+00:00 Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.bostontechnologyreview.com/article/910224335-aura-biosciences-announces-ceo-transition-as-company-advances-phase-3-compass-trial-toward-enrollment-completion Boston Technology Review en PressRelease 2026-05-04T10:01:00+00:00 Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.bostontechnologyreview.com/article/910224345-scilex-holding-company-announces-its-board-of-directors-approved-may-26-2026-as-the-payment-date-of-the-previously-announced-dividend-of-dream-bowl Boston Technology Review en PressRelease 2026-05-04T10:00:00+00:00 Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the… https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg https://www.bostontechnologyreview.com/article/910216010-what-is-the-best-internet-solution-for-business-travel-why-holafly-for-business-is-becoming-the-preferred-choice-for-global-companies Boston Technology Review en PressRelease 2026-05-04T08:54:07+00:00 What is the best internet solution for business travel? Why Holafly for Business is becoming the preferred choice for global companies https://ml-eu.globenewswire.com/media/ff9372ad-41f6-4acc-8266-5578d80cc425/medium/why-holafly-for-business-is-becoming-the-preferred-choice-fo.jpg https://www.bostontechnologyreview.com/article/910206820-virtune-ab-publ-virtune-hat-die-monatliche-neugewichtung-f-r-april-2026-des-virtune-crypto-altcoin-index-etps-durchgef-hrt Boston Technology Review en PressRelease 2026-05-04T08:06:34+00:00 Virtune AB (Publ) („Virtune“) hat die monatliche Neugewichtung für April 2026 des Virtune Crypto Altcoin Index ETPs durchgeführt https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/ https://www.bostontechnologyreview.com/article/910206825-virtune-ab-publ-virtune-has-completed-the-monthly-rebalancing-for-april-2026-of-its-virtune-crypto-altcoin-index-etp Boston Technology Review en PressRelease 2026-05-04T08:06:34+00:00 Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for April 2026 of its Virtune Crypto Altcoin Index ETP https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/logo-png.png https://www.bostontechnologyreview.com/article/910206829-virtune-ab-publ-virtune-har-genomf-rt-den-m-natliga-rebalanseringen-f-r-april-2026-av-virtune-crypto-altcoin-index-etp Boston Technology Review en PressRelease 2026-05-04T08:06:34+00:00 Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för april 2026 av Virtune Crypto Altcoin Index ETP https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/ https://www.bostontechnologyreview.com/article/910188220-proper-hills-launches-ultra-slim-alloy-magnetic-power-bank-for-design-conscious-consumers Boston Technology Review en PressRelease 2026-05-04T05:30:58+00:00 Proper Hills Launches Ultra-Slim Alloy Magnetic Power Bank for Design-Conscious Consumers https://ml.globenewswire.com/media/382df764-328b-4049-8389-ac0950f52367/medium/proper-hills-just-made-a-power-bank-thinner-than-a-pencil-th.png https://www.bostontechnologyreview.com/article/910177238-unbounded-vision-dreame-window-cleaning-robot-debuts-in-north-america-redefining-vertical-cleaning-with-precision-technology Boston Technology Review en PressRelease 2026-05-04T04:17:56+00:00 Unbounded Vision: Dreame Window Cleaning Robot Debuts in North America, Redefining Vertical Cleaning with Precision Technology https://ml.globenewswire.com/Resource/Download/d9c436d7-c9c5-46ff-8495-5a11d321f6a3/3-5.png https://www.bostontechnologyreview.com/article/910162333-lakefusion-raises-7-5m-seed-financing-to-redefine-master-data-management-mdm-natively-on-databricks Boston Technology Review en PressRelease 2026-05-04T02:02:10+00:00 LakeFusion Raises $7.5M Seed Financing to Redefine Master Data Management (MDM) Natively on Databricks https://ml.globenewswire.com/media/78680f0e-2aae-4cb5-8bf0-8e3d8bb6b896/medium/lakefusion-raises-7-5m-seed-financing-to-redefine-master-dat.png https://www.bostontechnologyreview.com/article/910150844-novelty-nobility-taps-agc-biologics-to-further-develop-bispecific-drug-candidate Boston Technology Review en PressRelease 2026-05-04T00:00:00+00:00 Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate https://ml.globenewswire.com/media/cecf4f80-22df-4bbf-b0a7-f50b9acf9495/medium/agc-biologics-and-novelty-nobility-representatives-meet.png https://www.bostontechnologyreview.com/article/910150881-agc Boston Technology Review en PressRelease 2026-05-04T00:00:00+00:00 ノベルティ・ノビリティ、AGCバイオロジクスと提携し、二重特異性抗体候補薬の開発を推進 https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1qYQ==/tiny/AGC-Biologics-Inc-.png https://www.bostontechnologyreview.com/article/910150885-novelty-nobility-agc-biologics Boston Technology Review en PressRelease 2026-05-04T00:00:00+00:00 노벨티 노빌리티 (Novelty Nobility), 이중특이성 항체 개발 위해 AGC Biologics와 협력 확대 https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1rbw==/tiny/AGC-Biologics-Inc-.png https://www.bostontechnologyreview.com/article/910145359-crypto-news-today-alphapepe-presale-ai-dex-hits-final-testing-whilst-bitcoin-price-prediction-points-to-120-000 Boston Technology Review en PressRelease 2026-05-03T23:30:00+00:00 Crypto News Today: AlphaPepe Presale AI DEX Hits Final Testing Whilst Bitcoin Price Prediction Points to $120,000 https://ml.globenewswire.com/media/2c8b0156-2a64-4138-b75f-f7aaa8bdfd49/medium/alphapepe.jpg https://www.bostontechnologyreview.com/article/910130237-neuro-salt-under-investigation-full-pink-salt-trick-consumer-report-reveals-shocking-hidden-risks Boston Technology Review en PressRelease 2026-05-03T20:52:12+00:00 Neuro Salt Under Investigation: Full "Pink Salt Trick" Consumer Report Reveals Shocking Hidden Risks https://ml.globenewswire.com/media/5b7201ce-5f4e-4a97-9fe8-95a77e66b2b7/medium/neuro-salt.png https://www.bostontechnologyreview.com/article/910111834-luma-glasses-unveiled-does-lumaglasses-smart-ai-glasses-really-works-read-luma-glasses-consumer-report Boston Technology Review en PressRelease 2026-05-03T18:16:40+00:00 Luma Glasses Unveiled: Does LumaGlasses Smart AI Glasses Really Works? Read Luma Glasses Consumer Report! https://ml.globenewswire.com/media/c2a2f020-e4e2-491b-aa89-89d3efaa0309/medium/luma-glasses.png https://www.bostontechnologyreview.com/article/910074985-russian-oil-asset-fund-launches-public-website-and-solana-token-information-hub-for-roaf Boston Technology Review en PressRelease 2026-05-03T13:00:00+00:00 Russian Oil Asset Fund Launches Public Website and Solana Token Information Hub for $ROAF https://ml.globenewswire.com/media/a1ac6677-6dcc-4559-8941-b2ce8d5537ad/small/555-jpg.jpg https://www.bostontechnologyreview.com/article/910068316-bsstrategy-introduces-ai-powered-trading-workspace-for-strategy-development-and-portfolio-management Boston Technology Review en PressRelease 2026-05-03T12:00:00+00:00 BsStrategy Introduces AI-Powered Trading Workspace for Strategy Development and Portfolio Management https://ml.globenewswire.com/media/29228b48-2078-4e24-8423-55e6f010abde/medium/bsstrategy-logo.png https://www.bostontechnologyreview.com/article/910026702-stellarspace-stellt-bei-einer-auftaktveranstaltung-im-silicon-valley-produkte-der-neuen-generation-f-r-die-industrielle-automatisierung-vor Boston Technology Review en PressRelease 2026-05-03T05:09:19+00:00 StellarSpace stellt bei einer Auftaktveranstaltung im Silicon Valley Produkte der neuen Generation für die industrielle Automatisierung vor https://ml.globenewswire.com/Resource/Download/30183e94-1d9e-4c76-980e-bb4a59888b14/image2.png https://www.bostontechnologyreview.com/article/910026705-stellarspace-presenta-i-prodotti-di-automazione-industriale-di-nuova-generazione-all-evento-di-lancio-nella-silicon-valley Boston Technology Review en PressRelease 2026-05-03T05:09:19+00:00 StellarSpace presenta i prodotti di automazione industriale di nuova generazione all’evento di lancio nella Silicon Valley https://ml.globenewswire.com/Resource/Download/670deeb7-29d8-4511-a37d-3bf43c3f7439/image2.png https://www.bostontechnologyreview.com/article/910026708-stellarspace-silikon-vadisi-lansman-etkinli-inde-yeni-nesil-end-striyel-otomasyon-r-nlerini-lk-defa-tan-tt Boston Technology Review en PressRelease 2026-05-03T05:09:19+00:00 StellarSpace, Silikon Vadisi Lansman Etkinliğinde Yeni Nesil Endüstriyel Otomasyon Ürünlerini İlk Defa Tanıttı https://ml.globenewswire.com/Resource/Download/fcc7913a-5f01-4e26-8286-5362ebe4e600/image2.png